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ABSTRACT 
Bioinorganic photochemistry is a rapidly advancing research area in the field of 
bioinorganic chemistry. This project seeks to build upon the growing field by 
synthesizing and analyzing new photodynamic therapy (PDT) agents. There are three 
major generations of PDT agents. The first generation consists of chemically modified 
natural hematoporphyrins, which are not of great interest in the phototherapeutic field 
due to their low distinguishability between tumor cells and healthy cells, and extended 
skin photosensitivity in patients. The second generation consists of organic dyes, 
aromatic hydrocarbons, polypyrolics complexes, and semi-conductors, but is also not of 
much interest due to the same issues as the first generation. The third generation of PDT 
agents, the focus of this project, consists of tetrapyrroles and porphyrins. Porphyrins are 
essential because they can accept many different metals in their core, which result in 
changes of its properties for both therapeutic and photodynamic purposes. Porphyrins are 
also found in other biological molecules such as heme, chlorophyll, and vitamin B12. 
This project specifically focuses on metalloporphyrins encompassing manganese, and if 
these porphyrins display a high DNA cleavage rate they could be used in place of the first 
and second generation PDT agents.  MnTDCLPP, MnTTFMPP, and MnTECP are the 
specific metalloporphyrins being analyzed in this project. 
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Introduction 
Photodynamic therapy, also called photochemotherapy, is used in many areas of 
medicine to shrink tumors, treat skin diseases, and deactivate viruses, such as HIV-1 and 
HSV-1.4 The use of light for medicinal purposes has been studied for a long time, and its 
role as a warmer and anti-depressant has been known since ancient times.1 However, 
understanding the role of light in biological processes and chemical reactions has become 
a growing field in the area of bioinorganic chemistry. All of the mechanisms involved in 
tumor destruction by photodynamic therapy are not yet known, but the general process of 
photodynamic therapy is the conversion of light energy to chemical energy through a 
photosensitizer. The sensitizer is a dye that is activated when exposed to light with the 
proper wavelength for the sensitizer to absorb.3 When the photosensitizer reacts with 
molecular oxygen in the presence of the light an oxygenated product that is detrimental to 
the cell is the result.3 Most photosensitizers are naturally occurring or a chemical 
modification of naturally occurring biological compounds. Photosensitizers typically 
contain a tetrapyrrole center, which is the part of the molecule that is sensitive to the light 
and is activated. The ideal photosensitizer for photodynamic therapy can act as a catalyst, 
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is chemically stable, is retained in tumor cells longer than in normal cells, has high 
absorption at wavelengths from  650-800nm, and has low dark toxicity so that the 
photosensitizer is not activated until exposed to the treatment laser.2 Most 
photosensitizers are retained in both healthy cells and tumor cells and have maximum 
absorption at wavelengths shorter than the therapeutic window of 650-800nm (Figure 1).2 
As a result, photodynamic therapy agents are usually restricted to skin diseases and 
surface level tumors because the laser does not penetrate further than one centimeter into 
tissue. The longer the wavelength the deeper the laser penetrates into the tissue. 
Depending on the type of tumor, the tissue can transmit or scatter the light differently 
(Figure 2), and light in the phototherapeutic window can penetrate 50-200% deeper than 
light below that window.1 
 
Figure 1: Spectral analysis of biological compounds and the therapeutic window 1 
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Figure 2: Visual of light transmittance, refraction, and reflection by tissue 1 
Photodynamic therapy works by first injecting the patient with the agent to get it 
into the blood stream. Mice studies have shown that about 1% of the photosensitizer dose 
is retained in the blood stream after 24 hour, and that 35% can remain in the body after 
192 hours.3 The tumor site is then exposed to the laser with the wavelength that 
corresponds to the photosensitizer’s maximum absorption. In photodynamic therapy the 
photosensitizer goes from its ground state to its first excited state upon absorption of the 
light.1 The excited compound is then converted to its excited triplet state through 
intersystem crossing. In the excited triplet state it can undergo further chemical reactions 
to produce a radical intermediate and reactive singlet oxygen.1 There are three major 
modes of attack of photodynamic therapy. The first is direct cell death in the form of 
apoptosis, which results from the toxic form of the oxygen that is released. Photodynamic 
therapy can directly induce apoptosis without the signal transduction processes that are 
sometimes missing in tumor cells.4 The second is indirect cell death in which the oxygen 
destroys blood vessels needed to supply the cells with nutrients. The final mode of attack 
is cell death from immune system response such as inflammation.1  
 There are also three different generations of photodynamic therapy (PDT) agents. 
The first generation consists of chemically modified natural hematoporphyrins.
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The third generation of PDT agents, the focus of this project, consists of 
metalloporphyrins which contain a tetrapyrrole center.
membered conjugated carbon ring and 18 
bioorganic compounds such as hemoglobin, chlorophyll, and vitamin B12. Tetrapyrroles 
are important because they can accept many different metal io
distinguishability
engal and methylene blue, aromatic hydrocarbons 
ues as the first; 
onjugated ring structures.
3:  Hematoporphyrin and rose bengal 5, 6 
1
 Tetrapyrroles possess a 16
π electrons. They are found in many natural 
ns into its core to alter its 
Pullen 4 
1
 This 
 between 
nts 
1
 The 
 
-
Pullen 5 
 
properties for photodynamic purposes. These metal ions make the compound unique and 
specific to different photodynamic treatments.  
The porphyrins that were studied in this research project were manganese inserted 
metalloporphyrins named, MnTDCLPP, MnTTFMPP, and MnTECP (Figure 4). It is 
known that molecular oxygen can react with catalytic amounts of oxidation-reduction 
active metal ions to produce a radical capable of cleaving DNA.2 Therefore, the potential 
of these compounds as photodynamic therapy agents can be assessed by how well they 
cleave DNA when activated with a laser. DNA cleavage can be analyzed using DNA Gel 
Electrophoresis, and the compounds can be studied using UV-Visible Spectroscopy.  
Recent work in this laboratory utilizing calf thymus DNA indicated that all three 
manganese metalloporphyrins could cleave DNA, but the amount of cleavage is difficult 
to ascertain due to the smearing in the gels.7,8 Due to these results, our work focused on 
plasmids which are much smaller and easier to visualized via gel electrophoresis. 
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Figure 4: Manganese inserted metalloporphyrins MnTDCLPP (top left), MnTTFMPP 
(top right), and MnTECP (bottom middle)9, 10 
Experimental/Methods 
Gel Preparation 
All of the gel electrophoresis analyses were performed using a 0.7% agarose 
(Sigma) which was prepared with 0.5XTris-acetate-EDTA (TAE) buffer. The gels were 
run at 125 volts for approximately 1 hour in a Fisher brand unit and they were stained 
using Edvotek InstaStain Ethidium Bromide Sheets for approximately 10 min. The gels 
were photographed under UV light via a UVP Digital Imaging System to visually assess 
the DNA for the appearance of cleavage. 
 
 
Mn
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Preparation of DNA Plasmids  
A 50ng/µL solution of DNA plasmid (pBR322 or pUC19 from Biolabs) was 
prepared by adding 2µL of 1000µg/mL stock solution to 38µL of 0.5XTAE. Varying 
amounts of 50ng/µL DNA plasmid (4-16µL) were further diluted to 50µL using 
0.5XTAE.  
Preparation of Metalloporphyrins 
The metalloporphyrins that were used in this experiment (MnTDCLPP, 
MnTTFMPP, and MnTECP) were synthesized by Dr. Cynthia P. Tidwell’s laboratory at 
Montevallo University in Montevallo, Alabama. The stock solution of 3.175x10-3M 
MnTDCLPP was diluted to 3.175x10-4M, the stock solution of 1.99x10-3M MnTTFMPP 
was diluted to 1.53x10-4M, and the stock solution of MnTECP was prepared by adding 
4mg MnTECP to 11.5mL DMF. All dilutions were prepared with 
Dimethylformamide (DMF) as solvent.  
DNA Control 
As a control, all DNA plasmids were exposed to the laser without any 
photodynamic therapy agents. These samples were prepared with 50µL of 5.0ng/µL 
pBR322 or pUC19. The DNA was exposed to the Coherent Innova 90C Argon Laser set 
at 488nm, 10.0A, and 0.07W. Samples were taken after 0, 10, 30, 60, and 90 minutes of 
exposure. Exactly 10µL aliquots were taken and prepared for gel electrophoresis with 
0.7% agarose in 0.5XTAE buffer.  
Porphyrin Control 
The effects of white light (400-800nm) and laser light (488nm) on each of the 
metalloporphyrins were assessed by preparing 50µL samples of the metalloporphyrin 
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solutions (3.175x10-4M MnTDCLPP, 1.53x10-4M MnTTFMPP, and 1.793x10-1mg/mL 
MnTECP) and placing them on a white light apparatus (Figure 5). Shimadzu UV 1601 
was used to take a UV spectrum of the metalloporphyrins after various amounts (5, 15, 
30, and 60 minutes) of light exposure and the spectra were analyzed. The apparatus 
consisted of a 150 watt white light bulb positioned under a pyrex dish that contained 
water at 30C. A glass sheet sat on top of the pyrex dish and held the microtiter plate 
containing the metalloporphyrin samples. 
 
 
Figure 5: White light apparatus 
For the Argon laser setup, the samples were placed in either a microtiter plate or a 
microfuge tube in direct path of the laser light. The heat generated from the laser is not a 
concern and therefore a cooling system is not necessary.  
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Figure 6: The 488 nm argon laser apparatus. As light was emitted from the laser a mirror 
reflected the laser at a 90 angle toward the tripod ring stand were the eppendorf tubes 
containing the sample were placed. The samples had to be activated one at a time.  
DNA Cleavage Experiments 
The minimum amount of metalloporphyrin and laser activation time needed to 
cleave the DNA was assessed. The optimization began by combining arbitrary amounts of 
plasmids and porphyrin and diluting the samples to 45µL using 0.5XTAE. The chosen 
amounts were 5µL of 50ng/µL DNA and 10µL of metalloporphyrins solutions (3.175x10-
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4M MnTDCLPP, 1.53x10-4M MnTTFMPP, and 1.793x10-1mg/mL MnTECP). A control 
was also prepared with 10µL of 0.5XTAE in place of the metalloporphyrin solution. The 
samples were exposed to a 488nm laser for 30 minutes to analyze the effects of the 
activated metalloporphyrin on the DNA. If the DNA showed evidence of cleavage after 
30 minutes, then the laser activation time was decreased until no cleavage was evident. 
This was accomplished by taking 10µL aliquots of the samples on the laser apparatus in 
3-5 minute intervals and analyzing them with 0.7% agarose gel electrophoresis. If the 
DNA continued to show signs of cleavage, even after minute amounts of laser activation 
time, then the metalloporphyrin concentration was decreased until the difference in DNA 
cleavage could be visualized at varying amounts of laser activation. 
Data and Results 
 
Figure 7: Varying amounts of 50ng/µL pBR322 were diluted to 50µL samples using 
0.5XTAE and analyzed using gel electrophoresis. 
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Figure 8: A 50µL sample of 5.0ng/µLpBR322 was exposed to a 488nm laser set at 10.0A 
and 0.07W for 90 minutes. Exactly 10µL aliquots of the sample were taken at 0, 10, 30, 
60, and 90 minutes, and analyzed using gel electrophoresis. 
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Figure 9: Exactly 50µL samples of the metalloporphyrin solutions were placed on a white 
light apparatus and a UV Spectrum of the metalloporphyrins was analyzed before and 
after activation with the white light. 
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Figure 10: Samples were prepared by combining 5µL of 50ng/µL pBR322, 10µL of 
metalloporphyrin stock solution, and 50µL 0.5XTAE, and then exposed to 488nm laser 
for 30 minutes. DNA cleavage was assessed using 0.7% agarose gel electrophoresis. 
 
Figure 11: Samples were prepared by combining 5µL of 50ng/µL pBR322, 10µL of 
metalloporphyrin stock solution, and 35µL of 0.5XTAE, and then exposed to 488nm laser 
for 10, 15, and 20 minutes. DNA cleaveage was assessed using 0.7% agarose gel 
electrophoresis. 
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(a) 
 (b) 
Figure 12: (a) Samples containing 5.556ng/µL pBR322 and varying concentrations of 
each metalloporphyrin were exposed to a 488nm laser for 3, 6, and 9 minutes. The DNA 
cleavage by the porphyrin was assessed using 0.7% agarose gel electrophoresis. (b) The 
metalloporphyrin concentration was decreased while the plasmid concentration and laser 
activation time remained constant to further assess its effects on DNA cleavage.  
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Table 1: Visual determination of DNA cleavage using DNA Gel Electrophoresis and a 
UV light box when various amounts of MnTDCLPP and laser activation time were 
combined with 5.556ng/µL pBR322 
 
Table 2: Visual determination of DNA cleavage using DNA Gel Electrophoresis and UV 
light box when various amounts of MnTTFMPP and laser activation time were combined 
with 5.556ng/µL pBR322 
Discussion/Conclusion 
The first objective of this research project was to determine the minimum amount 
of plasmid (pBR322) needed to visualize a band in a 0.7% agarose gel. As shown in 
MnTDCLPP
(nmol/µL)
3 minutes of laser 
activation
6 minutes of laser 
activation
9 minutes of laser 
activation
1.59 Complete Cleavage Complete Cleavage Complete Cleavage
1.27 Partial Cleavage Partial Cleavage Partial Cleavage 
0.95 No Cleavage No Cleavage No Cleavage
0.64 No Cleavage No Cleavage No Cleavage
0.32 No Cleavage No Cleavage No Cleavage
MnTTFMPP
(nmol/µL)
3 minutes of laser 
activation
6 minutes of laser 
activation
9 minutes of laser 
activation
0.77 Complete Cleavage Complete Cleavage Complete Cleavage
0.62 Complete Cleavage Complete Cleavage Complete Cleavage
0.46 Complete Cleavage Complete Cleavage Complete Cleavage
0.31 Partial Cleavage Complete Cleavage Complete Cleavage
0.15 No Cleavage No Cleavage No Cleavage
Pullen 16 
 
Figure 7, when 4µL of 50ng/µL of pBR322 was diluted to 50µL a band was slightly 
visible. This indicates that a plasmid concentration of at least 4ng/µL is necessary to 
visualize a band. Once the plasmid concentration was optimized, control experiments 
were performed to ensure that the laser did not damage the DNA and that white light did 
not activate the metalloporphyrins. Figure 8 demonstrates that the optimum amount of 
plasmid (5ng/µL) was not degraded by the 488nm laser for up to 90 minutes of laser 
exposure. The control band that had not been exposed to laser was equal in size to all 
other bands that were exposed to the laser for various lengths of time. Majority of the 
experiments require less than 30 minutes of laser activation, so the 90 minute control 
window made certain that there would be no damage to the DNA during our experiments. 
The next control experiment involved the effects of white light on the metalloporphyrins. 
The UV spectra of the metalloporphyrins were assessed before and after exposure to 
white light via the white light apparatus (Figure 5). Figure 9 illustrates the UV spectra of 
MnTTFMPP and MnTECP before and after white light activation. These spectra are 
almost identical indicating no activation or conformation of the compounds by the white 
light. With the knowledge that the laser will not degrade the DNA and that the white light 
will not activate the metalloporphyrins, the primary objective of this research project 
could be studied.  
The purpose of this research project was to discovering the optimum 
concentrations of metalloporphyrins and laser exposure time needed to cleave our sample 
of DNA. Figure 10 demonstrates that when the arbitrary amounts of plasmid (5µL of 
50ng/µL pBR322) and metalloporphyrins (10µL of 3.175x10-4M MnTDCLPP, 1.53x10-
4M MnTTFMPP, or 1.793x10-1mg/mL MnTECP) were exposed to the 488nm laser for 30 
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minutes, the DNA was cleaved in the presence of MnTDCLPP and MnTTFMPP, but not 
in the presence of MnTECP. Because 38.64 ng/µL of MnTECP was not able to cleave the 
DNA sample after 30 minutes of laser activation the focus shifted to MnTDCLPP and 
MnTTFMPP. The laser activation time was steadily decreased, and Figure 11 shows that 
our porphyrin concentration continued to cleave the DNA sample after just 10 minutes of 
laser activation. The next step was to decrease the metalloporphyrin concentration and 
assess DNA cleavage when laser activation was less than ten minutes. The gels from 
these experiments can be visualized in Figure 12; the tabulated analyses for DNA 
cleavage at varying metalloporphyrin concentrations and laser activation can be seen in 
Tables 1 and 2. The information in Table 1 leads to the conclusion that the optimum 
conditions to cleave 5.556ng/µL pBR322 using MnTDCLPP is 1.59nmol/µL and 3 
minutes of laser activation. Table 2 asserts that the optimum conditions to cleave the 
DNA sample using MnTTFMPP is 0.31nmol/µL and 3 minutes of laser activation. 
According to these results, MnTTFMPP cleaves DNA with the smallest concentration 
and 3 minutes is optimum laser activation time. The high-valent oxo-manganese 
porphyrin seems promising as a likely intermediate in DNA cleavage. Future work on this 
project includes the analysis of the type of DNA cleavage using HPLC, the activation of 
our metalloporphyrins using transilluminator at 312 nm, visible light at 532nm, and He-
Ne laser at 632.8nm, and the analysis of DNA cleavage with other metalloporphyrins 
such as CuTECP. 
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